Comparisons of pericarditis patients on rilonacept with and without concomitant constrictive pericarditis: a case-control study

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Tom Kai Ming Wang

Cleveland Clinic, Cleveland (United States of America)

7 More presentations in this session

Presentation thumbnail

Rilonacept reduces pericarditis recurrence risk: clinical outcomes from the RESONANCE patient registry

Doctor P. Cremer (Chicago, US)

Abstract Slides Video

Presentation thumbnail

Pushing boundaries, not the heart: a comparative look at pericarditis recurrence in athletes

Doctor E. Angelu (Turin, IT)

Abstract Slides Video

Presentation thumbnail

Unveiling hidden myocardial dysfunction in acute pericarditis: the prognostic power of GLS

Doctor A. Andreis (Turin, IT)

Abstract Slides Video

Presentation thumbnail

Rilonacept as monotherapy for long-term recurrent pericarditis management: sustained disease control over three years

Doctor D. Lotan (New York, US)

Abstract Slides Video

Presentation thumbnail

Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: a case series

Doctor F. Moda (Milan, IT)

Abstract Slides Video

Access the full session

Session thumbnail

Pericarditis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Rilonacept as monotherapy for long-term recurrent pericarditis management: sustained disease control over three years

Congress Presentation

Recurrent pericarditis: is Anakinra the only solution? Diagnostic and therapeutical insights from long-term follow-up of a large monocentric cohort

Congress Session

Personalised therapy for pericardial disease: the right treatment for the right patient

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources